[HTML][HTML] Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum

S Ferré, LI Sarasola, C Quiroz, F Ciruela - Neuropharmacology, 2023 - Elsevier
Adenosine plays a very significant role in modulating striatal glutamatergic and
dopaminergic neurotransmission. In the present essay we first review the extensive …

Unifying family A GPCR theories of activation

BG Tehan, A Bortolato, FE Blaney, MP Weir… - Pharmacology & …, 2014 - Elsevier
Several new pairs of active and inactive GPCR structures have recently been solved
enabling detailed structural insight into the activation process, not only of rhodopsin but now …

Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models

N Plattner, F Noé - Nature communications, 2015 - nature.com
Understanding the structural mechanisms of protein–ligand binding and their dependence
on protein sequence and conformation is of fundamental importance for biomedical …

Protein-peptide association kinetics beyond the seconds timescale from atomistic simulations

F Paul, C Wehmeyer, ET Abualrous, H Wu… - Nature …, 2017 - nature.com
Understanding and control of structures and rates involved in protein ligand binding are
essential for drug design. Unfortunately, atomistic molecular dynamics (MD) simulations …

Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer

J Bonaventura, G Navarro… - Proceedings of the …, 2015 - National Acad Sciences
Adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key
modulators of striatal neuronal function. It has been suggested that the psychostimulant …

Nanobodies to study protein conformational states

T Uchański, E Pardon, J Steyaert - Current opinion in structural biology, 2020 - Elsevier
Highlights•Nanobodies lock distinct conformational states of proteins.•Nanobodies stabilize
protein complexes.•Nanobodies can be functionally expressed as intrabodies to study …

The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

Control of glutamate release by complexes of adenosine and cannabinoid receptors

A Köfalvi, E Moreno, A Cordomí, NS Cai… - BMC biology, 2020 - Springer
Background It has been hypothesized that heteromers of adenosine A 2A receptors (A2AR)
and cannabinoid CB 1 receptors (CB1R) localized in glutamatergic nerve terminals mediate …

A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies

F Magnani, MJ Serrano-Vega, Y Shibata… - Nature protocols, 2016 - nature.com
The thermostability of an integral membrane protein (MP) in detergent solution is a key
parameter that dictates the likelihood of obtaining well-diffracting crystals that are suitable for …

[HTML][HTML] How do adenosine A2A receptors regulate motor function?

A Mori - Parkinsonism & related disorders, 2020 - Elsevier
Adenosine A 2A receptor antagonism is a new therapeutic strategy in the symptomatic
treatment of Parkinson's disease (PD). This review addresses how adenosine A 2A …